Artificial Placenta - A Lung assist device for pre-term neonates

点击翻译按钮获取中文摘要

Premature births are associated with significant morbidity and mortality. Neonates, especially those with very low birth-weights and born at less than 28 weeks of gestational age have a very low survival rate, with respiratory distress caused by lack of surfactants in underdeveloped and immature lungs being a leading cause. Current methods for respiratory support in neonates, such as mechanical ventilation and extracorporeal membrane oxygenation (ECMO) are invasive and often lead to several long-term side effects or severe complications. We have developed and patented a biomedical device - the artificial placenta (AP) - which is physiologically similar to in-utero conditions and overcomes some of the issues associated with traditional methods. Crucially, due to its microfluidic design is it the only one suited for the neonatal population. We propose to commercialize our device and request funds for a Market Assessment of respiratory devices for neonates which will inform a product development and business plans for successful commercialization.